ATE113597T1 - Antagonisten von excitatorischen aminosäuren. - Google Patents

Antagonisten von excitatorischen aminosäuren.

Info

Publication number
ATE113597T1
ATE113597T1 AT90109226T AT90109226T ATE113597T1 AT E113597 T1 ATE113597 T1 AT E113597T1 AT 90109226 T AT90109226 T AT 90109226T AT 90109226 T AT90109226 T AT 90109226T AT E113597 T1 ATE113597 T1 AT E113597T1
Authority
AT
Austria
Prior art keywords
antagonists
amino acids
excitatory amino
excitatory
directed
Prior art date
Application number
AT90109226T
Other languages
English (en)
Inventor
Boyd L Harrison
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE113597T1 publication Critical patent/ATE113597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
AT90109226T 1989-05-16 1990-05-16 Antagonisten von excitatorischen aminosäuren. ATE113597T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (1)

Publication Number Publication Date
ATE113597T1 true ATE113597T1 (de) 1994-11-15

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90109226T ATE113597T1 (de) 1989-05-16 1990-05-16 Antagonisten von excitatorischen aminosäuren.

Country Status (19)

Country Link
EP (1) EP0398283B1 (de)
JP (1) JP3014001B2 (de)
KR (1) KR0169107B1 (de)
CN (1) CN1027369C (de)
AT (1) ATE113597T1 (de)
AU (1) AU626418B2 (de)
DE (1) DE69013750T2 (de)
DK (1) DK0398283T3 (de)
ES (1) ES2066035T3 (de)
FI (1) FI95795C (de)
GR (1) GR3014893T3 (de)
HU (1) HU214322B (de)
IE (1) IE64671B1 (de)
IL (1) IL94377A (de)
NO (1) NO177141C (de)
NZ (1) NZ233641A (de)
PT (1) PT94042B (de)
TW (1) TW207950B (de)
ZA (1) ZA903588B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
ATE137225T1 (de) * 1991-02-27 1996-05-15 Merrell Pharma Inc Dihydrochinolin nmda antagonisten
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
AU5533996A (en) * 1996-04-04 1997-10-29 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
JP4234344B2 (ja) * 1999-12-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有複素環化合物
ES2311920T3 (es) * 2001-03-14 2009-02-16 Grunenthal Gmbh Tiazolopirimidinas sustituidas como analgesicos.
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
PT2262500T (pt) 2008-04-11 2016-08-16 Merck Patent Gmbh Derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk)
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
EP0398283B1 (de) 1994-11-02
FI902416A0 (fi) 1990-05-15
TW207950B (de) 1993-06-21
FI95795B (fi) 1995-12-15
NO902179D0 (no) 1990-05-15
ES2066035T3 (es) 1995-03-01
IL94377A (en) 1997-01-10
HU214322B (hu) 1998-03-02
DE69013750D1 (de) 1994-12-08
JP3014001B2 (ja) 2000-02-28
NO177141B (no) 1995-04-18
NZ233641A (en) 1992-07-28
IL94377A0 (en) 1991-03-10
KR900018112A (ko) 1990-12-20
DE69013750T2 (de) 1995-05-24
FI95795C (fi) 1996-03-25
IE901750L (en) 1990-11-16
HU903031D0 (en) 1990-09-28
PT94042B (pt) 1997-05-28
EP0398283A1 (de) 1990-11-22
CN1047292A (zh) 1990-11-28
HUT54657A (en) 1991-03-28
KR0169107B1 (ko) 1999-01-15
CN1027369C (zh) 1995-01-11
ZA903588B (en) 1991-02-27
NO902179L (no) 1990-11-19
PT94042A (pt) 1991-01-08
IE64671B1 (en) 1995-08-23
JPH0311067A (ja) 1991-01-18
AU5491490A (en) 1990-11-22
DK0398283T3 (da) 1994-11-28
AU626418B2 (en) 1992-07-30
GR3014893T3 (en) 1995-05-31
NO177141C (no) 1995-07-26

Similar Documents

Publication Publication Date Title
ATE113597T1 (de) Antagonisten von excitatorischen aminosäuren.
ATE126436T1 (de) Antagonisten von exzitatorischen aminosäuren.
DE3763968D1 (de) Ester von thiolcarboxylsaeuren.
DK0422938T3 (da) Fibrinogenreceptorantagonister
DE69021530T2 (de) Neue Derivate von A-nor-3-Carboxysteroiden.
DK565987D0 (da) Substituerede aminosyrer
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
DE69018071T2 (de) Herstellung von peroxysäuren.
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
DE3678053D1 (de) Herstellungsverfahren von trifluoressigsaeurealkylestern.
DE3765784D1 (de) Zusammensetzung von aminosaeuren.
PT92503A (pt) Processo para a preparacao de novos derivados peptidicos com accao anti-coagulante
DE3751586D1 (de) Antitumor-Aminosäuren und Peptid-Derivate von 1,4-bis[(Aminoalkyl und Hydroxyaminoalkyl)amino]5,8-Dihydroxyanthraquinonen.
DE69030774D1 (de) Optisch aktive Diastereoisomersalze von Tetrahydro-2-furancarbonsäure
DE68914950D1 (de) Aminsalze von 1,4,2-Oxazaphospholidin-2-alkoxy-2-oxid-4-essigsäuren.
KR890010740U (ko) 공업용 재봉틀의 다리
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
DK196489A (da) Carbamatderivater samt en fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee